Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States

Background: Glioblastoma multiforme (GBM) is a fatal type of brain tumor with a high incidence among elderly people. Temozolomide (TMZ) has proven to be an effective chemotherapeutic agent with significant survival benefits. This study aimed to evaluate the economic outcomes of radiotherapy (RT) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jigang, Tong, Xin, Han, Mingyang, Zhao, Songfeng, Ji, Linjin, Qin, Yongkai, He, Zilong, Pan, Yuesong, Wang, Chunhui, Liu, Aihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502816/
https://www.ncbi.nlm.nih.gov/pubmed/34646141
http://dx.doi.org/10.3389/fphar.2021.743979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502816/
https://www.ncbi.nlm.nih.gov/pubmed/34646141
http://dx.doi.org/10.3389/fphar.2021.743979

Ejemplares similares